Immunocore Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Immunocore Holdings (IMCR).

Price Target Range — 11 Quarters

Analyst Consensus — 14 Analysts

10Buy

4Hold

Consensus RatingOutperform# Analysts14Avg. Consensus PT$64Upside to Avg. PT+115.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 21, 2026	JP Morgan	Jessica Fye	Reinstates	Overweight	$50
Aug 3, 2026	Mizuho	Graig Suvannavejh	PT Raise	Neutral	$34→$35
Apr 20, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
Apr 14, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
Mar 16, 2026	Jefferies	Clara Dong	Downgrade	Buy→Hold	$48→$33
Feb 26, 2026	Needham	Gil Blum	PT Raise	Buy	$71→$75
Feb 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
Jan 7, 2026	UBS	Michael Yee	Assumes	Sell→Buy	$24→$55
Nov 10, 2025	Morgan Stanley	Andrew Galler	PT Raise	Equal-Weight	$34→$36
Oct 31, 2025	Wells Fargo	Eva Fortea Verdejo	Initiate	Overweight	$60
Oct 22, 2025	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
Sep 18, 2025	Guggenheim	Paul Jeng	Assumes	Neutral	—
Jun 2, 2025	HC Wainwright & Co.	Patrick Trucchio	Maintained	Buy	$100
May 8, 2025	Oppenheimer	Jeff Jones	PT Raise	Outperform	$85→$86
May 7, 2025	Barclays	Peter Lawson	PT Cut	Overweight	$66→$52
Apr 14, 2025	JP Morgan	Jessica Fye	PT Cut	Overweight	$54→$50
Apr 10, 2025	Needham	Gil Blum	Maintained	Buy	$71
Apr 7, 2025	Mizuho	Graig Suvannavejh	PT Cut	Neutral	$38→$33
Mar 12, 2025	HC Wainwright & Co.	Patrick Trucchio	Maintained	Buy	$100
Mar 12, 2025	Needham	Gil Blum	Maintained	Buy	$71

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

JP Morgan analyst Jessica Fye reinstates Immunocore Holdings (NASDAQ:IMCR) with a Overweight and announces $50 price target.

Benzinga Newsdesk

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

Mizuho analyst Graig Suvannavejh maintains Immunocore Holdings (NASDAQ:IMCR) with a Neutral and raises the price target from $34 to $35.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 price target.

Benzinga Newsdesk

PRO
Jefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33

Jefferies analyst Clara Dong downgrades Immunocore Holdings (NASDAQ:IMCR) from Buy to Hold and lowers the price target from $48 to $33.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Immunocore Holdings, Raises Price Target to $75

Needham analyst Gil Blum maintains Immunocore Holdings (NASDAQ:IMCR) with a Buy and raises the price target from $71 to $75.

Benzinga Newsdesk

Immunocore Holdings PLC

ニュース

パートナーシップ

ベンジンガ・グローバル

Immunocore Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
Jefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33

PRO
Needham Maintains Buy on Immunocore Holdings, Raises Price Target to $75

People Also Watch

People Also Watch

Immunocore Holdings PLC

ニュース

パートナーシップ

ベンジンガ・グローバル

Immunocore Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PROMizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PROJefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33

PRONeedham Maintains Buy on Immunocore Holdings, Raises Price Target to $75

People Also Watch

People Also Watch

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
Jefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33

PRO
Needham Maintains Buy on Immunocore Holdings, Raises Price Target to $75